Alerts will be sent to your verified email
Verify EmailALKEM
Alkem Laboratories
|
Abbott India
|
Aurobindo Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
178.0 . | n/a | 853.0 . |
Number of ANDA's Approved By USFDA
|
152.0 . | n/a | 704.0 . |
Number of ANDA's Filed in Europe
|
18.0 | n/a | n/a |
Number of ANDA's Approved in Europe
|
12.0 | n/a | n/a |
Number of ANDA's Filed in Australia
|
42.0 | n/a | n/a |
Number of ANDA's Approved by Australia
|
32.0 | n/a | n/a |
Domestic Sales Growth - YoY
|
6.5 % | 7.2 % | n/a |
R&D as a % of Total Sales
|
4.3 % | 0.02 % | 5.6 % |
Financials
|
|||
5 yr Average ROE
|
17.42 % | 28.3 % | 13.97 % |
5yr average Equity Multiplier
|
1.42 | 1.45 | 1.51 |
5yr Average Asset Turnover Ratio
|
0.89 | 1.15 | 0.71 |
5yr Avg Net Profit Margin
|
13.9 % | 17.01 % | 12.77 % |
Price to Book
|
5.24 | 17.95 | 2.29 |
P/E
|
27.96 | 47.37 | 20.26 |
5yr Avg Cash Conversion Cycle
|
-31.98 Days | -49.8 Days | -49.62 Days |
Inventory Days
|
55.32 Days | 47.03 Days | 59.48 Days |
Days Receivable
|
41.28 Days | 19.26 Days | 28.34 Days |
Days Payable
|
114.28 Days | 108.53 Days | 115.71 Days |
5yr Average Interest Coverage Ratio
|
24.2 | 83.18 | 43.78 |
5yr Avg ROCE
|
22.93 % | 36.46 % | 16.69 % |
5yr Avg Operating Profit Margin
|
18.1 % | 21.84 % | 19.28 % |
5 yr average Debt to Equity
|
0.21 | 0.0 | 0.21 |
5yr CAGR Net Profit
|
9.76 % | 15.17 % | 2.21 % |
5yr Average Return on Assets
|
12.26 % | 19.59 % | 9.18 % |
Shareholdings
|
|||
Promoter Holding
|
55.13 % | 74.99 % | 51.82 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 16.92 % |
Change in Promoter Holding (3 Yrs)
|
-2.0 % | 0.0 | -0.01 % |
Change in Mutual Fund Holding (3 Yrs)
|
7.45 % | 3.42 % | 8.12 % |
Alkem Laboratories
|
Abbott India
|
Aurobindo Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|